Deletion of a mycobacterial gene encoding a reductase leads to an altered cell wall containing β-oxo-mycolic acid analogues, and the accumulation of long-chain ketones related to mycolic acids



The MSMEG4722 mutant also showed a slightly slower growth rate than the parental mc2155
strain (Figure 2C; the OD
600 values at 24h correspond to 2×108 and 107 colony forming units/ ml
for mc2155 and
MSMEG4722 respectively). This wasn’t surprising as a similar growth defect
was observed when the homologous gene was deleted in
C. glutamicum, and a genome-wide
transposon screen predicted that the loss of the homologous gene in
M. tuberculosis would result
in a slow growth phenotype (Lea-Smith et al., 2007; Sassetti et al., 2003). Additionally, when
grown in LB broth, the mutant showed an increased sensitivity to the lipophilic antibiotic
rifampicin (MIC=0.125
μg∕ml) as compared to the parental strain mc2155 (MIC=16 μg∕ml), but
not to hydrophilic antibiotics like isoniazid and ethambutol. Wild type characteristics were
restored on complementation of the
MSMEG4722 mutant with plasmid-borne MSMEG4722
indicating that the observed phenotypes in the mutant strain were solely due to the loss of
MSMEG4722 (Figure 2B and C).

The MSMEG4722 mutant failed to synthesize mature mycolic acids

The predicted role of MSMEG4722 in mycolic acid motif formation and the observed changes in
the colony morphology of the
MSMEG4722 mutant prompted us to examine mycolic acids in
the mutant strain. If MSMEG4722 was indeed the reductase catalyzing the conversion of the
post Pks13,
α-alkyl, β-oxo fatty acyl intermediate, then the MSMEG4722 mutant would be
expected to accumulate this unreduced intermediate of mycolic acid biosynthesis (Figure 1A). A
standard procedure for release of mycolic acids from mycobacteria involves base hydrolysis of
cells using tetrabutyl ammonium hydroxide (TBAH). This is followed by phase-transfer
catalyzed derivatisation using methyl iodide that results in the formation of mycolic acid methyl



More intriguing information

1. Evaluating the Impact of Health Programmes
2. The name is absent
3. Weak and strong sustainability indicators, and regional environmental resources
4. EU enlargement and environmental policy
5. The name is absent
6. Delayed Manifestation of T ransurethral Syndrome as a Complication of T ransurethral Prostatic Resection
7. Standards behaviours face to innovation of the entrepreneurships of Beira Interior
8. The name is absent
9. On Social and Market Sanctions in Deterring non Compliance in Pollution Standards
10. Tobacco and Alcohol: Complements or Substitutes? - A Statistical Guinea Pig Approach